Patents Assigned to Imperial College of Science and Technology
  • Patent number: 8507673
    Abstract: Processes for the preparation of certain 5,7-diaminopyrazolo[1,5-?]pyrimidine compounds comprising the reaction of a primary or secondary amine and a protected 5-halo-7-aminopyrazolo[1,5-?]pyrimidine compound in solvent system comprising water and one or more organic solvents, optionally in the presence of an exogenous base.
    Type: Grant
    Filed: June 9, 2011
    Date of Patent: August 13, 2013
    Assignees: Emory University, Imperial College of Science and Technology
    Inventors: Dennis C. Liotta, James P. Snyder, Ashutosh S. Jogalekar, Anthony G. M. Barrett, Matthew John Fuchter, Matthew J. Cook, Sebastian H. B. Kroll
  • Patent number: 8067424
    Abstract: This invention provides a class of compounds which are useful for specifically inhibiting cyclin-dependent kinases. This class of compounds finds use in treating diseases resulting from inappropriate activity of cyclin-dependent kinases, including cancer, viral infections (e.g., HIV) neurodegenerative disorders (e.g. Alzheimer's disease), and cardiovascular disorders (e.g. atherosclerosis). Moreover, certain members of this class are particularly useful for inhibiting cyclin-dependent kinase 7 and are especially useful for the treatment of breast cancer.
    Type: Grant
    Filed: December 4, 2009
    Date of Patent: November 29, 2011
    Assignees: Emory University, Imperial College of Science and Technology
    Inventors: Ashutosh S. Jogalekar, James P. Snyder, Dennis C. Liotta, Anthony G. M. Barrett, Raoul Charles Dalmedo Stuart Coombes, Simak Ali, Aleksandra Siwicka, Jan Brackow, Bodo Scheiper
  • Publication number: 20040228881
    Abstract: Methods and compositions for modulating neurite outgrowth in damaged neural endplates. Also disclosed are methods for introducing drugs, ribozymes, antisense oligonucleotides and defective receptor genes within neurons.
    Type: Application
    Filed: September 18, 2003
    Publication date: November 18, 2004
    Applicants: Allergan, Inc., Imperial College of Science and Technology
    Inventors: Dolly J. Oliver, Kei Roger Aoki, Anton De Paiva
  • Patent number: 6007805
    Abstract: Individual subtypes of interferon-.alpha. (IFN-.alpha.) have been found to have different antiviral activity in different cell types and are therefore used to prevent or treat viral infections in cell types in which they are most active. The individual subtype of choice has relatively low antiviral activity in other celltypes to reduce the risk of side effects. IFN-.alpha..sub.10 and/or IFN-.alpha..sub.17 are preferred for use in treating viral lung infections and IFN-.alpha..sub.8 is preferred for use in treating viral liver infections.
    Type: Grant
    Filed: September 24, 1996
    Date of Patent: December 28, 1999
    Assignee: Imperial College of Science and Technology
    Inventors: Graham Russell Foster, Howard Christopher Thomas
  • Patent number: 5575819
    Abstract: An artificial ligament for connecting across a skeletal joint comprises a bundle of fibers 1 each comprising a plurality of filaments 1a of polyethylene terephthalate. The ligament is constructed by winding a plurality of turns of the fiber 1 onto a winding apparatus and then binding the ends to form loops 4.Also disclosed is a ligament fixation device in the form of a cylindrical grommet, and a tensioning instrument for use in implanting an artificial ligament.
    Type: Grant
    Filed: November 28, 1994
    Date of Patent: November 19, 1996
    Assignee: Imperial College of Science and Technology
    Inventor: Andrew Amis